To Get Help Now
Click Here
Today's Date:

Humira Sued For Fungal Infection Side Effects

AddThis Social Bookmark Button

Frederick Delano of Tennessee has filed a product liability lawsuit in U.S. District Court for the Western District of Tennessee against Humira maker Abbot Laboratories alleging that company failed to adequately warn consumers about serious side effects of the drug, including development of serious fungal infections.

Humira was FDA approved in 2003 for the treatment of rheumatoid arthritis, and later for treatment of psoriatic arthritis, Crohn’s disease, chronic psoriasis and ankylosing spondylitis. In September 2008,  the FDA issued a warning that Humira and other TNF blockers, carried the risk of serious and sometimes life threatening fungal infections including histoplasmosis, blastomycosis and coccidioidmycosis. The FDA ordered a black box warning be placed on all TNF blockers, and ordered the manufacturers to write a letter to health care providers alerting them of the changes and potential side effects, including that people living in the Mississippi and Ohio River Valleys were at greater risk for fungal infection development, and that immune-suppressant drugs could further increase the risk. Abbot stalled the letter until 2010.

Delano, who lived in the named river valleys and was taking an immune-suppressant, started treatment with Humira in October 2008. He was diagnosed with disseminated histoplasmosis in February 2009.

Delano claims in the lawsuit that the fungal infection nearly killed him. He is seeking compensatory and punitive damages. disclaimer: This article: Humira Sued For Fungal Infection Side Effects was posted on Wednesday, June 15th, 2011 at 7:57 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.